Search
for
Sort by
Research 30 of 1000+
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata
- Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA
- [ADAPTIVE REGULATORY MECHANISMS OF ALOPECIA AREATA].
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Cross‐sectional study of hair loss patterns in 122 Korean systemic lupus erythematosus patients: A frequent finding of non‐scarring patch alopecia
- A study of clinical and dermoscopic features in alopecia areata at a tertiary referral center
- Assessment of prognostic markers of alopecia areata in pediatric patients
- Dermoscopic evaluation of therapeutic response to intralesional triamcinolone acetonide in the treatment of Alopecia areata
- Topical Mechlorethamine Restores Autoimmune-Arrested Follicular Activity in Mice with an Alopecia Areata-Like Disease by Targeting Infiltrated Lymphocytes
- Serum Granulysin Levels in Vitiligo and Alopecia Areata: A Potential Biomarker for Disease Activity and Dermoscopic Evaluation
- Alopecia areata: trichoscopic markers in determining disease activity
- DIAGNOSTIC VALUE OF TRICHOSCOPY IN THE DIFFERENTIAL DIAGNOSIS OF VARIOUS FORMS OF ALOPECIA
- Gene Expression of CD70 and CD27 Is Increased in Alopecia Areata Lesions and Associated with Disease Severity and Activity
- Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- РОЛЬ ОКСИДАТИВНОГО СТРЕССА И МИТОХОНДРИАЛЬНОЙ ДИСФУНКЦИИ В ПРОГРЕССИРОВАНИИ АЛОПЕЦИИ
- Serum IL-21 Level and Its Relation to Activity and Severity of Alopecia Areata
- Clinical and Trichoscopic Patterns of Hair Loss in Systemic Lupus Erythematosus and its Correlation with Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Oxidative Stress in Alopecia Areata and its Association with Disease Severity, Treatment and Autoimmunity
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- Global sex disparities in lifetime risk of alopecia areata: a systematic analysis from the global burden of disease study, 1990 to 2021
- Thyroid hormone action on skin.
- New insights into the phenomenon of remissions and relapses in autoimmune diseases and the puzzle of benign autoantibodies in healthy individuals
- Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls
- Serum 25-Hydroxy Vitamin D Level in Patients with Alopecia Areata and Its Relationship with Severity of the Disease